FdaApplication

ANDA 209613

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAMNEAL PHARMACEUTICALS CO GMBH
application_typeANDA
approval_date2018-09-28

Products (2)

ProductActive ingredientStrengthDosage form
TERIFLUNOMIDETERIFLUNOMIDE14MGTABLET;ORAL
TERIFLUNOMIDETERIFLUNOMIDE7MGTABLET;ORAL

2 products